No, it is not mutually exclusive! A case report of a girl with two genetic diagnoses: Craniofrontonasal dysplasia and pontocerebellar hypoplasia type 1B von Ibrahim, Iman, Scriver, Tara, Basalom, Shuaa A.

Volltext

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity von DAMARAJU, Vijaya L, SCRIVER, Tara, MOWLES, Delores, KUZMA, Michelle, RYAN, Anderson J, CASS, Carol E, SAWYER, Michael B

Volltext

A de novo deletion in a boy with cerebral palsy suggests a refined critical region for the 4q21.22 microdeletion syndrome von Zarrei, Mehdi, Merico, Daniele, Kellam, Barbara, Engchuan, Worrawat, Scriver, Tara, Jokhan, Rikash, Wilson, Michael D., Parr, Jeremy, Lemire, Edmond G., Stavropoulos, Dimitri J., Scherer, Stephen W.

Volltext

Effects of gefitinib and vandetanib on human equilibrative nucleoside transporter 1 and on gemcitabine cytotoxicity von Damaraju, Vijaya L., Scriver, Tara, Mowles, Delores, Cass, Carol E, Sawyer, Michael B.

Volltext